RECRUITING

Prostate Cancer IMAGing IN Early Detection (IMAGINED Trial)

Talk to us

Conditions

Prostate CancerDetection of prostate cancersoftware application

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The researchers hope to learn if specific types of MRI software and techniques can help improve early prostate cancer detection at time of a MRI-guided prostate biopsy.

Official Title

Validation, Calibration, and Translation of Restriction Spectrum Imaging Signal Maps to Enhance MRI Diagnostic Capabilities in Prostate Cancer

Quick Facts

Study Start:2023-12-04
Study Completion:2028-04
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05882253

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:Not specified
Sexes Eligible for Study:MALE
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Selected to undergo an MRI-fusion prostate needle biopsy of the prostate.
  2. * Able to provide informed consent
  1. * prior diagnosis of prostate cancer (Grade Group \>1)
  2. * metastatic prostate cancer
  3. * prior prostate cancer treatment
  4. * contraindication to prostate biopsy (e.g., on anticoagulation that cannot be safely discontinued)
  5. * inability to undergo MRI (e.g., too large to be accommodated in a scanner or with an implant incompatible with MRI).
  6. * Bilateral hip replacement
  7. * Unable to provide informed consent.

Contacts and Locations

Study Contact

Michael A Liss, MD, PhD
CONTACT
(210) 567-0548
Liss@uthscsa.edu
Brandi Weaver, BA
CONTACT
210-567-0178
WeaverB@uthscsa.edu

Principal Investigator

Michael A Liss, MD, PhD
PRINCIPAL_INVESTIGATOR
University of Texas Health Science Center San Antonio

Study Locations (Sites)

Audie Murphie VA
San Antonio, Texas, 78229
United States
The University of Texas Health Science Center at San Antonio, Medical Arts and Research Center
San Antonio, Texas, 78229
United States
University Health System
San Antonio, Texas, 78229
United States

Collaborators and Investigators

Sponsor: The University of Texas Health Science Center at San Antonio

  • Michael A Liss, MD, PhD, PRINCIPAL_INVESTIGATOR, University of Texas Health Science Center San Antonio

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-12-04
Study Completion Date2028-04

Study Record Updates

Study Start Date2023-12-04
Study Completion Date2028-04

Terms related to this study

Keywords Provided by Researchers

  • Detection of prostate cancer
  • software application

Additional Relevant MeSH Terms

  • Prostate Cancer